Arabic Arabic English English French French German German
dark

Evofem Biosciences Announces Pricing of $50 Million Public Offering

Company Would Receive up to an Additional $50 Million Upon Exercise of Accompanying Short-Term Warrants Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Idera Pharmaceuticals Announces Corporate Updates

Next Post

Agilex Biolabs’ Toxicology Tapped for SARS-CoV-2 Vaccine Research

Related Posts
Total
0
Share